Related Experiment Video
Updated: Jun 21, 2025

04:57
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
10.1K
Absolute risk from double nested case-control designs: cause-specific proportional hazards models with and without
Minjung Lee1, Mitchell H Gail2
1Department of Statistics, Kangwon National University, Chuncheon, Gangwon 24341, South Korea.
Biometrics
|July 12, 2024
Summary
This study introduces enhanced methods for analyzing competing risks in double nested case-control (DNCC) studies. Augmented estimators improve efficiency for estimating absolute risks and relative hazards in complex survival data.
Area of Science:
- Biostatistics
- Epidemiology
- Survival Analysis
Background:
- Competing risks present challenges in survival analysis.
- Double nested case-control (DNCC) designs offer efficient data collection but require specialized estimation methods.
- Estimating absolute risks and relative hazards accurately is crucial for understanding disease progression and outcomes.
Purpose of the Study:
- To develop and validate efficient estimators for cause-specific proportional hazards models using DNCC data.
- To improve the estimation of absolute risks and relative hazards in the presence of competing risks.
- To leverage complete covariate data from the phase-two sample and partial data from the full cohort.
Main Methods:
- Utilized design-weighted estimators based on inverse sampling probabilities for DNCC data.
- Augmented standard estimators with a term to incorporate additional cohort data, enhancing efficiency.
- Established asymptotic properties and derived consistent variance estimators for the proposed methods.
- Conducted simulations to assess the performance of the estimators in practical sample sizes.
Main Results:
- Augmented design-weighted estimators demonstrated greater efficiency compared to standard design-weighted estimators.
- The proposed asymptotic methods exhibited nominal operating characteristics in simulations.
- Validated the methodology using real-world data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Conclusions:
- The developed augmented estimators provide a more efficient approach for analyzing competing risks in DNCC studies.
- The methods are robust and suitable for practical application in epidemiological research.
- Accurate estimation of absolute risks and relative hazards is achievable with the proposed techniques.
Related Concept Videos
Relative Risk
143
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
143
Hazard Ratio
110
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
110
Hazard Rate
102
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
102
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Odds Ratio
123
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
123
Assumptions of Survival Analysis
121
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
121

